Literature DB >> 10384061

Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases.

M Oshima1, A Maeda, S Ishioka, K Hiyama, M Yamakido.   

Abstract

To determine the role of C-C chemokines in the pathogenesis of granulomatous lung diseases, we studied the mRNA levels of C-C chemokines, regulated on activation normal T expressed and secreted (RANTES), macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and monocyte chemoattractant protein (MCP)-1 in bronchoalveolar lavage (BAL) cells obtained from patients with sarcoidosis (n = 17), hypersensitivity pneumonitis (HP) (n = 4), and cryptogenic fibrosing alveolitis (CFA) (n = 10) using the reverse transcription-polymerase chain reaction (RT-PCR) technique. The mRNA levels of RANTES, MIP-1alpha, and MIP-1beta in BAL cells were significantly correlated with the lavaged lymphocyte proportion, and a significant inverse correlation was observed between the mRNA level of MIP-1beta and the CD4/CD8 ratio of lavaged lymphocytes. Among the three diseases, the mRNA levels of RANTES and MIP-1alpha were significantly higher in the patients with sarcoidosis or HP compared with those in the patients with CFA. The level of MIP-1beta mRNA was significantly higher in the HP patients compared with that in the patients with sarcoidosis or CFA. No significant differences were observed in the level of MCP-1 mRNA among the three diseases. Thus, RANTES and MIP-1alpha were suggested to be important in the pathogenesis of granulomatous inflammation in sarcoidosis and HP. MIP-1beta might play an important role in the pathogenesis of HP, mediating the recruitment of lymphocytes specific to HP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10384061     DOI: 10.1007/pl00007643

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  9 in total

1.  The role of MIP-1alpha in experimental hypersensitivity pneumonitis.

Authors:  M Schuyler; K Gott; V French
Journal:  Lung       Date:  2004       Impact factor: 2.584

2.  Viral regulation of RANTES expression during human cytomegalovirus infection of endothelial cells.

Authors:  M Billstrom Schroeder; G S Worthen
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Fcgamma receptors modulate pulmonary inflammation by activating innate immune cells in murine hypersensitivity pneumonitis.

Authors:  Hyo Jin Park; Hye Sung Kim; Doo Hyun Chung
Journal:  Immune Netw       Date:  2010-02-28       Impact factor: 6.303

4.  Toll-like receptor 6 drives interleukin-17A expression during experimental hypersensitivity pneumonitis.

Authors:  Daniel J Fong; Cory M Hogaboam; Yosuke Matsuno; Shizuo Akira; Satoshi Uematsu; Amrita D Joshi
Journal:  Immunology       Date:  2010-01-11       Impact factor: 7.397

5.  Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis.

Authors:  Vyacheslav Palchevskiy; Nastran Hashemi; Stephen S Weigt; Ying Ying Xue; Ariss Derhovanessian; Michael P Keane; Robert M Strieter; Michael C Fishbein; Jane C Deng; Joseph P Lynch; Robert Elashoff; John A Belperio
Journal:  Fibrogenesis Tissue Repair       Date:  2011-04-04

6.  A role for MCP-1/CCR2 in interstitial lung disease in children.

Authors:  Dominik Hartl; Matthias Griese; Thomas Nicolai; Gernot Zissel; Christine Prell; Dietrich Reinhardt; Dolores J Schendel; Susanne Krauss-Etschmann
Journal:  Respir Res       Date:  2005-08-11

7.  Cytokine gene polymorphisms in Pigeon Breeder's Disease expression.

Authors:  Cláudia Freitas; Bruno Lima; Natália Martins; Natália Melo; Patrícia Mota; Hélder Novais-Bastos; Helena Alves; Oksana Sokhatska; Luís Delgado; António Morais
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-09-30       Impact factor: 0.670

Review 8.  Manipulation of the immune system by non-small cell lung cancer and possible therapeutic interference.

Authors:  Helmut H Popper
Journal:  Cancer Drug Resist       Date:  2020-09-12

9.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.